218 related articles for article (PubMed ID: 37584286)
1. Advances in next-generation sequencing and emerging technologies for hematologic malignancies.
Kwon R; Yeung CCS
Haematologica; 2024 Feb; 109(2):379-387. PubMed ID: 37584286
[TBL] [Abstract][Full Text] [Related]
2. Applications of next-generation sequencing in hematologic malignancies.
Ramkissoon LA; Montgomery ND
Hum Immunol; 2021 Nov; 82(11):859-870. PubMed ID: 33648805
[TBL] [Abstract][Full Text] [Related]
3. Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies.
Coccaro N; Tota G; Anelli L; Zagaria A; Specchia G; Albano F
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365599
[TBL] [Abstract][Full Text] [Related]
4. [Recommendations for laboratory standardization of next generation sequencing in hematological malignancies].
Xu CS; Li XQ; Liu HX; Li CB; Chen Z; Cai JP; Peng MT
Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(41):3204-3208. PubMed ID: 31694113
[TBL] [Abstract][Full Text] [Related]
5. Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies.
Thomas M; Sukhai MA; Zhang T; Dolatshahi R; Harbi D; Garg S; Misyura M; Pugh T; Stockley TL; Kamel-Reid S
Arch Pathol Lab Med; 2017 Jun; 141(6):759-775. PubMed ID: 28557600
[TBL] [Abstract][Full Text] [Related]
6. Korean Society for Genetic Diagnostics Guidelines for Validation of Next-Generation Sequencing-Based Somatic Variant Detection in Hematologic Malignancies.
Kim H; Yun JW; Lee ST; Kim HJ; Kim SH; Kim JW;
Ann Lab Med; 2019 Nov; 39(6):515-523. PubMed ID: 31240878
[TBL] [Abstract][Full Text] [Related]
7. Minimal Residual Disease Monitoring with Next-Generation Sequencing Methodologies in Hematological Malignancies.
Sánchez R; Ayala R; Martínez-López J
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185671
[TBL] [Abstract][Full Text] [Related]
8. Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory.
Kanagal-Shamanna R; Singh RR; Routbort MJ; Patel KP; Medeiros LJ; Luthra R
Expert Rev Mol Diagn; 2016; 16(4):461-72. PubMed ID: 26765348
[TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing-based panel testing for myeloid neoplasms.
Kuo FC; Dong F
Curr Hematol Malig Rep; 2015 Jun; 10(2):104-11. PubMed ID: 25933675
[TBL] [Abstract][Full Text] [Related]
10. [NGS-based multi-gene panel testing in hematological malignancies: therapeutic significance].
Maeda T
Rinsho Ketsueki; 2022; 63(4):302-307. PubMed ID: 35491220
[TBL] [Abstract][Full Text] [Related]
11. Rational "Error Elimination" Approach to Evaluating Molecular Barcoded Next-Generation Sequencing Data Identifies Low-Frequency Mutations in Hematologic Malignancies.
Mallampati S; Duose DY; Harmon MA; Mehrotra M; Kanagal-Shamanna R; Zalles S; Wistuba II; Sun X; Luthra R
J Mol Diagn; 2019 May; 21(3):471-482. PubMed ID: 30794984
[TBL] [Abstract][Full Text] [Related]
12. Machine Learning Predictability of Clinical Next Generation Sequencing for Hematologic Malignancies to Guide High-Value Precision Medicine.
Kim GYE; Noshad M; Stehr H; Rojansky R; Gratzinger D; Oak J; Brar R; Iberri D; Kong C; Zehnder J; Chen JH
AMIA Annu Symp Proc; 2021; 2021():641-650. PubMed ID: 35308914
[TBL] [Abstract][Full Text] [Related]
13. Next generation sequencing in hematolymphoid neoplasia.
Kuo FC
Semin Hematol; 2019 Jan; 56(1):2-6. PubMed ID: 30573040
[TBL] [Abstract][Full Text] [Related]
14. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
[TBL] [Abstract][Full Text] [Related]
15. Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies.
Levy MA; Santos S; Kerkhof J; Stuart A; Aref-Eshghi E; Guo F; Hedley B; Wong H; Rauh M; Feilotter H; Berardi P; Semenuk L; Yang P; Knoll J; Ainsworth P; McLachlin CM; Chin-Yee I; Kovacs M; Deotare U; Lazo-Langner A; Hsia C; Keeney M; Xenocostas A; Howlett C; Lin H; Sadikovic B
Eur J Haematol; 2019 Sep; 103(3):178-189. PubMed ID: 31177553
[TBL] [Abstract][Full Text] [Related]
16. Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing.
Ptashkin RN; Ewalt MD; Jayakumaran G; Kiecka I; Bowman AS; Yao J; Casanova J; Lin YD; Petrova-Drus K; Mohanty AS; Bacares R; Benhamida J; Rana S; Razumova A; Vanderbilt C; Balakrishnan Rema A; Rijo I; Son-Garcia J; de Bruijn I; Zhu M; Lachhander S; Wang W; Haque MS; Seshan VE; Wang J; Liu Y; Nafa K; Borsu L; Zhang Y; Aypar U; Suehnholz SP; Chakravarty D; Park JH; Abdel-Wahab O; Mato AR; Xiao W; Roshal M; Yabe M; Batlevi CL; Giralt S; Salles G; Rampal R; Tallman M; Stein EM; Younes A; Levine RL; Perales MA; van den Brink MRM; Dogan A; Ladanyi M; Berger MF; Brannon AR; Benayed R; Zehir A; Arcila ME
Nat Commun; 2023 Oct; 14(1):6895. PubMed ID: 37898613
[TBL] [Abstract][Full Text] [Related]
17. Current concepts and future directions for hemato-oncologic diagnostics.
Flach J; Shumilov E; Joncourt R; Porret N; Novak U; Pabst T; Bacher U
Crit Rev Oncol Hematol; 2020 Jul; 151():102977. PubMed ID: 32446181
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology.
Shumilov E; Flach J; Pabst T; Fiedler M; Angelillo-Scherrer A; Trümper L; Joncourt R; Kohlmann A; Bacher U
Crit Rev Oncol Hematol; 2018 Jun; 126():64-79. PubMed ID: 29759569
[TBL] [Abstract][Full Text] [Related]
19. The Value of Next-Generation Sequencing in the Screening and Evaluation of Hematologic Neoplasms in Clinical Practice.
Northrup V; Maybank A; Carson N; Rahmeh T
Am J Clin Pathol; 2020 Apr; 153(5):639-645. PubMed ID: 31875888
[TBL] [Abstract][Full Text] [Related]
20. Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.
Kluk MJ; Lindsley RC; Aster JC; Lindeman NI; Szeto D; Hall D; Kuo FC
J Mol Diagn; 2016 Jul; 18(4):507-15. PubMed ID: 27339098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
